
Cameron English
Director of Bio-Sciences @ACSHorg. Co-host Science Facts and Fallacies podcast @geneticliteracy. Contributor @BigThink.
Articles
-
1 week ago |
acsh.org | Cameron English |Chuck Dinerstein
Despite dramatically increasing the national debt, the Trump Administration has made controversial cuts to federal funding for research, including critical areas like vaccine development and disease prevention. Many scientists warn that these reductions threaten public health advancements and technological innovation. Have these cuts crossed a line? Let’s take a look.
-
3 weeks ago |
acsh.org | Cameron English
Recently, the American Medical Association warned that a key ingredient in nicotine vaping liquid "may also be used to make antifreeze, paint, solvents and artificial smoke." By falsely implying that vaping exposes users to a harmful industrial chemical, the AMA is effectively encouraging smokers to maintain their deadly habit when a far safer alternative is available.
-
3 weeks ago |
geneticliteracyproject.org | Cameron English
Cameron English, Jon Entine, Liza Dunn | June 5, 2025 XLinkedInFacebookRedditBlueskyThreads Listen to GLP Science Facts & Fallacies on iTunes, Spotify, Podbean and YouTube Podcasts. Or add the RSS feed to your favorite podcast app. Join our to get these stories and more delivered to your inbox. There’s a growing panic over per- and polyfluoroalkyl substances (PFAS), most recently targeting fluoropolymers used in medical devices. The issue is presented to the public as a grave health threat:...
-
3 weeks ago |
acsh.org | Cameron English
Last week, the American Medical Association (AMA) warned that a key ingredient in nicotine vaping liquid "may also be used to make antifreeze, paint, solvents and artificial smoke." By falsely implying that vaping exposes users to a harmful industrial chemical, the AMA is effectively encouraging smokers to maintain their deadly habit when a far safer alternative is available.
-
3 weeks ago |
acsh.org | Cameron English |Chuck Dinerstein
GLP-1 drugs like Ozempic are transforming weight loss and diabetes management. But no good deed goes unpunished, and the manufacturers of these medicines now face a wave of lawsuits, with plaintiffs claiming they weren't warned about rare but sometimes serious side effects. Is this litigation driven by solid evidence, or are the tort lawyers out for yet another unearned payday? Let's take a look.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 537
- Tweets
- 2K
- DMs Open
- No